Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2906
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)